Document is current
Any future updates will be listed below
-
Authors
Memon, Rakhshi
Asif, Muqaddas
Shah, Bushra Ali
Kiran, Tayyeba
Khoso, Ameer B
Tofique, Sehrish
Miah, Jahanara
Ahmad, Ayesha
Chaudhry, Imran
Chaudhry, Nasim
Husain, Nusrat
Edwards, Sarah J L
-
Funding
Funding for this research was provided by:
Medical Research Council (MR/R022461/1, MR/R022461/1, MR/R022461/1, MR/R022461/1, MR/R022461/1, MR/R022461/1)
- License Information
-
More Information
Article History
Received: 18 January 2024
Accepted: 14 October 2024
First Online: 15 November 2024
Declarations
:
: Not Applicable.
: IBC, NC, and NH have disclosed engagements encompassing presentations and consultancy roles with Eli Lilly, Bristol Myers Squibb, Lundbeck, AstraZeneca, and Janssen Pharmaceuticals. These interactions led to reimbursements for them or their respective employing institutions. NH and IBC have held positions as trustees at the PILL in the past. NH has also held roles as a trustee for organizations including Manchester Global Foundation, Lancashire Mind, and Abaseen Foundation, UK. Additionally, NH is an NIHR senior investigator and serves as the Director of Research and Innovation at Mersey Care NHS Foundation Trust. Importantly, none of the aforementioned companies maintain any financial stake in this research. RM is Director of Manchester Global Foundation and has also held trustee position at UK Association for Medical Aid to Pakistan (UKMAP) and PILL in the past.
: for the main study was obtained from the National Bioethics Committee of Pakistan (Ref: No.4–87/NBC419/19/1213) and the Research Ethics Committee University of Manchester (Ref: 2019-5024-10755). Ethics approval for RM’s thesis was granted by Science and Technology Department, University College London (Ref. STSEth159). All participants gave informed written consent to participate.
